SCHEMBL9889592

SCHEMBL9889592

CCC(O)(O)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17772055 0.76 TSHR (0.39)
SCHEMBL9476632 0.73 CES1 (0.37)
SCHEMBL4951244 0.72
SCHEMBL5365546 0.72
SCHEMBL867380 0.72
SCHEMBL3264919 0.71 CES1 (0.34)
SCHEMBL2428134 0.71
SCHEMBL85653 0.71 NR1H2 (0.36)
SCHEMBL12128282 0.71 TSHR (0.32)
SCHEMBL22623957 0.71 TSHR (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109485632-B Method for preparing cyclic sulfite 山东石大胜华化工集团股份有限公司 2021-05-07 CN disclosed
US-20120142063-A1 NITRILASE BIOCATALYSTS Codexis ,Inc. (US) 2012-06-07 US disclosed
EP-1954668-B9 HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2012-03-21 EP disclosed
EP-1954668-B1 HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2011-09-28 EP disclosed
WO-2011011630-A2 NITRILASE BIOCATALYSTS CODEXIS, INC. (US) 2011-01-27 WO disclosed
WO-2007062308-A2 HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-05-31 WO disclosed